Adjusted EBITDA -- $11.7 million, up 34% from the comparable 2024 quarter. Portfolio Drivers -- Revenue growth was driven by ...

Q3 2025 Earnings Call Transcript November 10, 2025 Kamada Ltd. misses on earnings expectations. Reported EPS is $0.09199 EPS, ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 14, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...

More parents today are sharing breast milk, and this shift feels almost like a movement quietly building from home to home.

Nearly two years ago, Chad Gluss went into cardiac arrest and wound up needing a heart transplant. In January, he will be ...

Just one win and three losses. A poor, indeed, very poor, record in the last two days of the championship for the Prato teams competing in Group B of Regional Division 1. Let's start with Montemurlo, ...

Whether infection of cells by individual virions occurs randomly or if there is some form (s) of competition or cooperativity between individual virions remains largely unknown for most virus-cell ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

REHOVOT, Israel, and HOBOKEN, N.J. , Nov. 04, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for ...

New research weighs in on whether sponges or comb jellies sit at the base of the animal family tree, and why the answer ...